Brogan Financial Inc. Purchases Shares of 393 UnitedHealth Group Incorporated (NYSE:UNH)

Brogan Financial Inc. bought a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 393 shares of the healthcare conglomerate’s stock, valued at approximately $207,000.

Several other hedge funds and other institutional investors have also made changes to their positions in UNH. Richelieu Gestion SA acquired a new position in UnitedHealth Group in the 4th quarter worth approximately $26,000. CGC Financial Services LLC grew its position in UnitedHealth Group by 1,000.0% in the 4th quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after purchasing an additional 50 shares during the last quarter. LFA Lugano Financial Advisors SA boosted its position in shares of UnitedHealth Group by 148.1% during the 4th quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock valued at $35,000 after acquiring an additional 40 shares in the last quarter. O Brien Wealth Partners LLC boosted its position in shares of UnitedHealth Group by 36.8% during the 4th quarter. O Brien Wealth Partners LLC now owns 78 shares of the healthcare conglomerate’s stock valued at $41,000 after acquiring an additional 21 shares in the last quarter. Finally, Friedenthal Financial bought a new position in shares of UnitedHealth Group in the fourth quarter worth about $42,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

Insider Transactions at UnitedHealth Group

In other news, EVP Erin Mcsweeney sold 1,236 shares of UnitedHealth Group stock in a transaction on Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the sale, the executive vice president now directly owns 9,364 shares in the company, valued at approximately $4,527,306.72. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 0.33% of the company’s stock.

UnitedHealth Group Trading Down 1.7 %

Shares of UNH stock traded down $8.66 during trading hours on Friday, hitting $508.17. 2,414,748 shares of the company were exchanged, compared to its average volume of 4,169,007. The firm has a market cap of $467.71 billion, a P/E ratio of 31.06, a P/E/G ratio of 1.51 and a beta of 0.55. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $554.70. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.85 and a current ratio of 0.85. The company has a 50 day simple moving average of $489.23 and a two-hundred day simple moving average of $510.92.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.63 by $0.28. The business had revenue of $99.80 billion during the quarter, compared to the consensus estimate of $99.23 billion. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. UnitedHealth Group’s revenue was up 8.6% compared to the same quarter last year. During the same quarter last year, the firm posted $6.26 EPS. Equities analysts anticipate that UnitedHealth Group Incorporated will post 27.6 EPS for the current year.

Analyst Ratings Changes

A number of brokerages recently issued reports on UNH. Morgan Stanley decreased their price objective on shares of UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating for the company in a report on Friday, April 5th. Wells Fargo & Company decreased their price objective on shares of UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating for the company in a report on Monday, April 8th. Bank of America reiterated a “buy” rating and issued a $675.00 price target on shares of UnitedHealth Group in a report on Thursday, March 7th. Deutsche Bank Aktiengesellschaft upped their price target on shares of UnitedHealth Group from $545.00 to $562.00 and gave the company a “buy” rating in a report on Friday, April 19th. Finally, Piper Sandler upped their price target on shares of UnitedHealth Group from $566.00 to $571.00 and gave the company an “overweight” rating in a report on Wednesday, April 17th. Three equities research analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company’s stock. According to MarketBeat.com, UnitedHealth Group presently has an average rating of “Moderate Buy” and a consensus price target of $570.05.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.